RxDoctor Payments DataLook up a doctor →

Joshua Hixson, MD

Family Medicine · Smyrna, TNNPI 1326056839

Payments from drug & device makers

$17,693in general payments, 2019–2025

Across 1,089 payments — averaging $16.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AstraZeneca$2K
  • Amgen$1K
  • AbbVie$1K
  • Pfizer$980
  • Boehringer Ingelheim$940
  • plus $9K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk165$2,281
AstraZeneca(2 entities)66$1,744
Amgen98$1,380
AbbVie(2 entities)60$1,096
Pfizer70$980
Boehringer Ingelheim64$940
Lilly USA, LLC59$887
GSK64$863
Takeda Pharmaceuticals U.S.A., Inc.40$585
Otsuka America Pharmaceutical, Inc.27$570
Sanofi-aventis U.S. LLC38$549
Bayer30$455
Johnson & Johnson28$430
Merck30$362
Biohaven Pharmaceutical Holding Company Ltd.11$360
Astellas Pharma US Inc20$350
Esperion Therapeutics, Inc.18$321
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC18$301
Eisai Inc.16$269
Novartis14$259
Exact Sciences16$250
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)10$197
Biohaven Pharmaceuticals, Inc.8$185
Dexcom, Inc.9$156
Axsome Therapeutics, Inc.7$130
Nestle Healthcare Nutrition Inc.7$125
Impel Pharmaceuticals Inc.7$118
Hologic Sales And Service, LLC2$118
Arbor Pharmaceuticals, Inc.8$114
Dynavax Technologies Corporation6$114
Teva Pharmaceuticals USA, Inc.6$87
Edwards Lifesciences2$79
Inspire Medical Systems, Inc.3$74
Supernus Pharmaceuticals, Inc.4$73
Bausch Health US, LLC4$68
Lundbeck LLC4$64
Sumitomo Pharma America, Inc.3$51
RGH Enterprises LLC1$42
VBI Vaccine (delaware) Inc.3$42
Xeris Pharmaceuticals, Inc.2$39
Phathom Pharmaceuticals, Inc.2$38
Aimmune Therapeutics, Inc.2$37
Avanir Pharmaceuticals, Inc.2$31
Insulet Corporation2$30
Amarin Pharma, Inc.2$30
E.r. Squibb & Sons, L.L.C.2$28
Cranial Technologies, Inc2$27
Currax Pharmaceuticals LLC2$27
Jazz Pharmaceuticals Inc.2$25
Sunovion Pharmaceuticals Inc.2$25
Antares Pharma, Inc.2$22
Agios Pharmaceuticals, Inc.1$20
Daiichi Sankyo Inc.1$19
Alnylam Pharmaceuticals Inc.1$16
Azurity Pharmaceuticals, Inc.1$15
IBSA Pharma Inc.1$15
Evoke Pharma, Inc.1$15
Shield Therapeutics Inc1$15
Boston Scientific1$15
Abbott1$15

How this compares

$17,693 in reported general payments places this provider in the 95th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee →

Medicare billing

Part B allowed, 2024
$104,483
Medicare patients
162
Services billed
1,888

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Smyrna

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →